Literature DB >> 11717370

Functional interactions between tumor and peripheral nerve: changes in excitability and morphology of primary afferent fibers in a murine model of cancer pain.

D M Cain1, P W Wacnik, M Turner, G Wendelschafer-Crabb, W R Kennedy, G L Wilcox, D A Simone.   

Abstract

We used a murine model to investigate functional interactions between tumors and peripheral nerves that may contribute to pain associated with cancer. Implantation of fibrosarcoma cells in and around the calcaneus bone produced mechanical hyperalgesia of the ipsilateral paw. Electrophysiological recordings from primary afferent fibers in control and hyperalgesic mice with tumor revealed the development of spontaneous activity (0.2-3.4 Hz) in 34% of cutaneous C-fibers adjacent to the tumor (9-17 d after implantation). C-fibers in tumor-bearing mice exhibited a mean decrease in heat threshold of 3.5 +/- 0.10 degrees C. We also examined innervation of the skin overlying the tumor. Epidermal nerve fibers (ENFs) were immunostained for protein gene product 9.5, imaged using confocal microscopy, and analyzed in terms of number of fibers per millimeter of epidermal length and branching (number of nodes per fiber). Divergent morphological changes were linked to tumor progression. Although branching of ENFs increased significantly relative to control values, in later stages (16-24 d after implantation) of tumor growth a sharp decrease in the number of ENFs was observed. This decay of epidermal innervation of skin over the tumor coincided temporally with gradual loss of electrophysiological activity in tumor-bearing mice. The development of spontaneous activity and sensitization to heat in C-fibers and increased innervation of cutaneous structures within the first 2 weeks of tumor growth suggest activation and sensitization of a proportion of C-fibers. The decrease in the number of ENFs observed in later stages of tumor development implicates neuropathic involvement in this model of cancer pain.

Entities:  

Mesh:

Year:  2001        PMID: 11717370      PMCID: PMC6763931     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  52 in total

1.  Immunohistochemical measurements of nerves and neuropeptides in diabetic skin: relationship to tests of neurological function.

Authors:  D M Levy; G Terenghi; X H Gu; R R Abraham; D R Springall; J M Polak
Journal:  Diabetologia       Date:  1992-09       Impact factor: 10.122

2.  The density of remaining nerve endings in human skin with and without postherpetic neuralgia after shingles.

Authors:  A L Oaklander
Journal:  Pain       Date:  2001-05       Impact factor: 6.961

3.  Local injection of endothelin-1 produces pain-like behavior and excitation of nociceptors in rats.

Authors:  A P Gokin; M U Fareed; H L Pan; G Hans; G R Strichartz; G Davar
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

Review 4.  Peripheral pain mechanisms.

Authors:  P Cesare; P McNaughton
Journal:  Curr Opin Neurobiol       Date:  1997-08       Impact factor: 6.627

5.  Establishment and characterization of cell lines derived from a transplantable rat malignant meningioma: morphological heterogeneity and production of nerve growth factor.

Authors:  K Tsujino; J Yamate; Y Tsukamoto; D Kumagai; Y Kannan; T Jippo; M Kuwamura; T Kotani; M Takeya; S Sakuma
Journal:  Acta Neuropathol       Date:  1997-05       Impact factor: 17.088

6.  Intraepidermal nerve fiber density in patients with painful sensory neuropathy.

Authors:  N R Holland; A Stocks; P Hauer; D R Cornblath; J W Griffin; J C McArthur
Journal:  Neurology       Date:  1997-03       Impact factor: 9.910

7.  Painful sensory neuropathy: prospective evaluation using skin biopsy.

Authors:  M I Periquet; V Novak; M P Collins; H N Nagaraja; S Erdem; S M Nash; M L Freimer; Z Sahenk; J T Kissel; J R Mendell
Journal:  Neurology       Date:  1999-11-10       Impact factor: 9.910

8.  Intradermal injection of capsaicin in humans produces degeneration and subsequent reinnervation of epidermal nerve fibers: correlation with sensory function.

Authors:  D A Simone; M Nolano; T Johnson; G Wendelschafer-Crabb; W R Kennedy
Journal:  J Neurosci       Date:  1998-11-01       Impact factor: 6.167

9.  Neurogenic hyperalgesia: the search for the primary cutaneous afferent fibers that contribute to capsaicin-induced pain and hyperalgesia.

Authors:  T K Baumann; D A Simone; C N Shain; R H LaMotte
Journal:  J Neurophysiol       Date:  1991-07       Impact factor: 2.714

10.  Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate.

Authors:  J B Nelson; S P Hedican; D J George; A H Reddi; S Piantadosi; M A Eisenberger; J W Simons
Journal:  Nat Med       Date:  1995-09       Impact factor: 53.440

View more
  41 in total

Review 1.  Mechanism of cancer pain.

Authors:  Brian L Schmidt; Darryl T Hamamoto; Donald A Simone; George L Wilcox
Journal:  Mol Interv       Date:  2010-06

2.  Acute and chronic administration of the cannabinoid receptor agonist CP 55,940 attenuates tumor-evoked hyperalgesia.

Authors:  Darryl T Hamamoto; Subhalakshmi Giridharagopalan; Donald A Simone
Journal:  Eur J Pharmacol       Date:  2006-12-09       Impact factor: 4.432

3.  Long lasting recruitment of immune cells and altered epi-perineurial thickness in focal nerve inflammation induced by complete Freund's adjuvant.

Authors:  Geoffrey M Bove; Wendy Weissner; Mary F Barbe
Journal:  J Neuroimmunol       Date:  2009-06-28       Impact factor: 3.478

4.  An improved behavioural assay demonstrates that ultrasound vocalizations constitute a reliable indicator of chronic cancer pain and neuropathic pain.

Authors:  Martina Kurejova; Ulrike Nattenmüller; Ullrich Hildebrandt; Deepitha Selvaraj; Sebastian Stösser; Rohini Kuner
Journal:  Mol Pain       Date:  2010-03-26       Impact factor: 3.395

5.  Functional interactions between tumor and peripheral nerve: morphology, algogen identification, and behavioral characterization of a new murine model of cancer pain.

Authors:  P W Wacnik; L J Eikmeier; T R Ruggles; M L Ramnaraine; B K Walcheck; A J Beitz; G L Wilcox
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

6.  Effects of the RANKL inhibitor, osteoprotegerin, on the pain and histopathology of bone cancer in rats.

Authors:  Martine P Roudier; Steven D Bain; William C Dougall
Journal:  Clin Exp Metastasis       Date:  2006-08-16       Impact factor: 5.150

7.  CB1 and CB2 receptor agonists promote analgesia through synergy in a murine model of tumor pain.

Authors:  Iryna A Khasabova; James Gielissen; Anisha Chandiramani; Catherine Harding-Rose; Desiree Abu Odeh; Donald A Simone; Virginia S Seybold
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

8.  Selective inhibition of JNK with a peptide inhibitor attenuates pain hypersensitivity and tumor growth in a mouse skin cancer pain model.

Authors:  Yong-Jing Gao; Jen-Kun Cheng; Qing Zeng; Zhen-Zhong Xu; Isabelle Decosterd; Xiaoyin Xu; Ru-Rong Ji
Journal:  Exp Neurol       Date:  2009-05-13       Impact factor: 5.330

9.  Behavioral characteristics of a mouse model of cancer pain.

Authors:  Bae Hwan Lee; Jinsil Seong; Un Jeng Kim; Ran Won; Jiyoung Kim
Journal:  Yonsei Med J       Date:  2005-04-30       Impact factor: 2.759

10.  Intrathecal administration of Resolvin D1 and E1 decreases hyperalgesia in mice with bone cancer pain: Involvement of endocannabinoid signaling.

Authors:  Iryna A Khasabova; Mikhail Y Golovko; Svetlana A Golovko; Donald A Simone; Sergey G Khasabov
Journal:  Prostaglandins Other Lipid Mediat       Date:  2020-07-31       Impact factor: 3.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.